CDK4/6 Inhibitor Palbociclib Amplifies the Radiosensitivity to Nasopharyngeal Carcinoma Cells via Mediating Apoptosis and Suppressing DNA Damage Repair
Xianhe Xie,1,* Weili Zheng,1,2,* Ting Chen,1,2 Wanzun Lin,1,2 Ziyuan Liao,1 Junjin Liu,1 Yin Ding1 1Department of Medical Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, People’s Republic of China; 2Department of Central Laboratory, The First Af...
Main Authors: | Xie X, Zheng W, Chen T, Lin W, Liao Z, Liu J, Ding Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cdk46-inhibitor-palbociclib-amplifies-the-radiosensitivity-to-nasophar-peer-reviewed-article-OTT |
Similar Items
-
Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma
by: Tong-Hong Wang, et al.
Published: (2021-09-01) -
CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation
by: Yi-Bo Hou, et al.
Published: (2019-08-01) -
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
by: Wei Chen, et al.
Published: (2015-03-01) -
Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature
by: Archya Dasgupta, et al.
Published: (2021-03-01) -
A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report
by: Jietao Lin, et al.
Published: (2020-07-01)